KENNETH BATE - 15 Jun 2023 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Brian J. Lynch**
Issuer symbol
MDGL
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 18:41:10 UTC
Previous filing
06 Jun 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Award $0 +1,198 $0.000000 1,198 15 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest on June 15, 2024, provided the Reporting Person continues in service with the Issuer on such date.

Remarks:

** As attorney-in-fact for Reporting Person